arrow
K

Kelly E. Dooley

Vanderbilt University Medical Center
H指数:48
被引数:9,248

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis

乙胺丁醇群体药代动力学和药效学:来自用于治疗结核病的III期确证性试验

2026-09-300
OAAI
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin
2025-12-300
OAAI
Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

固定剂量联合制剂bictegravir–emtricitabine–tenofovir alafenamide每日两次用于利福平基线结核病治疗期间的HIV治疗(INSIGHT研究):一项2b期、开放标签、随机非对照试验

2025-12-010
PRE
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design

肺结核治疗新型短程方案的第2C期临床试验:TBTC研究38/CRUSH-TB设计

2025-09-010
PRE
A clinical practice guideline for tuberculous meningitis

结核性脑膜炎临床实践指南

2025-08-180
PRE
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis

一项关于利福平与美罗培南联合阿莫西林/克拉维酸钾在利福平耐药肺结核成人患者中早期杀菌活性的2a期研究

2025-06-010
OAAI
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

同时启动以多替阿巴拉韦为基础的抗逆转录病毒治疗和每周一次利福平肼和异烟肼用于结核病预防在抗逆转录病毒初治的HIV感染者中的研究:一项开放标签、非随机、1/2期临床试验

2025-05-080
PRE
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes

4个月利福喷丁为基础的结核病治疗方案在糖尿病患者中的疗效与安全性

2025-03-010
OA
Clinical and diagnostic features of central nervous system tuberculosis in Indian children - a descriptive study
2024-09-120
OAAI
Lipid and Glucose Profiles in Pregnant Women With Human Immunodeficiency Virus (HIV) on Tenofovir-based Antiretroviral Therapy
2024-09-022
PRE
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations A Randomized Phase II Clinical Trial

大剂量异烟肼对katG突变介导的异烟肼耐药结核病缺乏早期杀菌活性随机II期临床试验

2024-08-013
PRE
Target regimen profiles for tuberculosis treatment

结核病治疗的目标方案概况

2024-08-011
OAAI
Multidrug-resistant tuberculosis

耐多药结核病

2024-03-2427
OA
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
2024-03-110
OAAI
Standards for clinical trials for treating TB
2023-12-013
OAAI